Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R S Gelman

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|March 19, 2009
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancerE L Mayer, A H Partridge, L N Harris, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1988
Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancerA Recht, W Silen, S J Schnitt, et al.
The New England Journal of Medicine|May 23, 1996
The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancerA Recht, S E Come, I C Henderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatmentG Falkson, R S Gelman, K J Pandya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancerG Falkson, R S Gelman, R Dreicer, et al.
Cancer Treatment Reports|October 1, 1987
Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agentsR S Gelman, D C Tormey, R Betensky, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 1995
Life-span, T-cell responses, and incidence of lymphomas in congenic miceM Salazar, T Leong, N Tu, et al.
Cancer|April 1, 1997
Breast-conserving therapy for stage I-II synchronous bilateral breast carcinomaS V Gollamudi, R S Gelman, G Peiro, et al.
Blood|June 25, 1998
Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individualsJ E Schmitz, M A Forman, M A Lifton, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 1999
Treatment-related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancerP H Hardenbergh, A Recht, S Gollamudi, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|March 19, 2009
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancerE L Mayer, A H Partridge, L N Harris, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1988
Time-course of local recurrence following conservative surgery and radiotherapy for early stage breast cancerA Recht, W Silen, S J Schnitt, et al.
The New England Journal of Medicine|May 23, 1996
The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancerA Recht, S E Come, I C Henderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatmentG Falkson, R S Gelman, K J Pandya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancerG Falkson, R S Gelman, R Dreicer, et al.
Cancer Treatment Reports|October 1, 1987
Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agentsR S Gelman, D C Tormey, R Betensky, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 1995
Life-span, T-cell responses, and incidence of lymphomas in congenic miceM Salazar, T Leong, N Tu, et al.
Cancer|April 1, 1997
Breast-conserving therapy for stage I-II synchronous bilateral breast carcinomaS V Gollamudi, R S Gelman, G Peiro, et al.
Blood|June 25, 1998
Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individualsJ E Schmitz, M A Forman, M A Lifton, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 1999
Treatment-related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancerP H Hardenbergh, A Recht, S Gollamudi, et al.
Pageof 5